Peptide Technology Ltd.
15Patents
0Active
15Granted
33Portfolio score
Filing activity: Aug 16, 1993 → Jul 30, 1999
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5545408A | Biocompatible implant for the timing of ovulation in mares | Human Necessities | 154 | Expired |
| US5756449A | Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease | Chemistry; Metallurgy | 56 | Expired |
| US5959087A | Tumour necrosis factor binding ligands | Chemistry; Metallurgy | 55 | Expired |
| US6262119A | Methods of treating immunopathologies using polyunsaturated fatty acids | Human Necessities | 52 | Expired |
| US5644034A | Tumour necrosis factor binding ligands | Chemistry; Metallurgy | 35 | Expired |
| US5561110A | Method for the treatment of the complications and pathology of diabetes | Human Necessities | 32 | Expired |
| US6376688B1 | Modified polyunsaturated fatty acids | Emerging Cross-Sectional Technologies | 30 | Expired |
| US6416757B1 | Tumor necrosis factor antibodies | Chemistry; Metallurgy | 11 | Expired |
| US5767156A | Polyunsaturated fatty acids and uses thereof | Human Necessities | 10 | Expired |
| US5795859A | Peptide which abrogates TNF and/or LPS toxicity | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5998476A | Synthetic polyunsaturated fatty acid analogues | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5587457A | Neutrophil stimulating peptides | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5795858A | Treatment or prevention of Crohn's disease and/or ulcerative colitis | Human Necessities | 1 | Expired |
| US6121237A | Neutrophil stimulating peptides | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5798335A | Method for the treatment or prevention of eczema/dermatitis | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.